top of page

Rapharma and Kelun Lifesciences have entered into a preliminary agreement

We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences (Pvt) Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023. It is Sri Lanka's first and only pharmaceutical manufacturing facility for sterile liquid injections and infusions. The headquarters of the company is based in Kandy on the island of Sri Lanka.


Thus, the intention of both parties to cooperate with each other in the international pharmaceutical business was expressed and documented. Sri Lankan pharmaceutical company Kelun Lifesciences (Pvt) Ltd was represented by its CEO Dr. Gyan Prakash Ujalayan. We clarify that we are dealing with a subsidiary of the Chinese Kelun Group http://www.kelun.com/, which it created in Sri Lanka with Indian partners.

The conclusion of agreements between the partners was devoted to the joint development and launch of medicines on international markets and the creation of a production center for the synthesis of medicines. The agreement covers the production in Sri Lanka of five important pharmaceutical ingredients being developed by Rapharma, the production of radio-pharmaceuticals that Rapharma has outlined in its 2023-2028 release strategy, as well as investments in this project, promoting the project to international markets, including presentations at reputable exhibitions and conferences.


Social network of the subsidiary company Kelun Lifesciences (Pvt) Ltd: https://lk.linkedin.com/company/kelun-life-sciences-pvt-ltd?trk=similar-pages

Lot 43-44 Industrial park, BOI

Pallekele

Kandy, Kandy, LK, Sri Lanka


ABOUT RAFARMA PHARMACEUTICALS

Rafarma Pharmaceuticals is a diversified pharmaceutical company dedicated to the new treatments and solutions development for patients in various fields. Regularly cooperating with leading research institutes and pharmaceutical companies around the world, the business has earned a reputation as a reliable manufacturer and distributor. Rafarma Pharmaceuticals has more than 25 programs in molecular biology, nuclear medicine, immunology, sustainable packaging, and many other fields at the moment.


For more information, please visit https://www.noyarp.com


CONTACTS:

RAFARMA PHARMACEUTICALS

babenko_press@rafapharm.com

+1 (307) 218-0292

Sheridan, Wyoming, 82801, USA


Source: Rafarma Pharmaceuticals, Inc.

Comments


bottom of page